Where CG operates in a non-hydrolytic fashion, it exhibits the capacity to activate platelets 99, which subsequently envelops tumor cells and transfers their major histocompatibility complex (MHC) into the same neoplastic cells, resulting in elevated levels of MHC on tumor cell surfaces. This evidence concerns the gene HLA-C and neoplasm.